154 related articles for article (PubMed ID: 28648774)
1. The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves.
Smadja DM; Susen S; Rauch A; Cholley B; Latrémouille C; Duveau D; Zilberstein L; Méléard D; Boughenou MF; Belle EV; Gaussem P; Capel A; Jansen P; Carpentier A
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1595-1602. PubMed ID: 28648774
[TBL] [Abstract][Full Text] [Related]
2. Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand Factor.
Poitier B; Chocron R; Peronino C; Philippe A; Pya Y; Rivet N; Richez U; Bekbossynova M; Gendron N; Grimmé M; Bories MC; Brichet J; Capel A; Rancic J; Vedie B; Roussel JC; Jannot AS; Jansen P; Carpentier A; Ivak P; Latremouille C; Netuka I; Smadja DM
Arterioscler Thromb Vasc Biol; 2022 Apr; 42(4):470-480. PubMed ID: 35139659
[TBL] [Abstract][Full Text] [Related]
3. Animal studies with the Carmat bioprosthetic total artificial heart.
Latrémouille C; Duveau D; Cholley B; Zilberstein L; Belbis G; Boughenou MF; Meleard D; Bruneval P; Adam C; Neuschwander A; Perles JC; Jansen P; Carpentier A
Eur J Cardiothorac Surg; 2015 May; 47(5):e172-8; discussion e178-9. PubMed ID: 25719178
[TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
[TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
[TBL] [Abstract][Full Text] [Related]
8. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.
Stockschlaeder M; Schneppenheim R; Budde U
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):206-16. PubMed ID: 24448155
[TBL] [Abstract][Full Text] [Related]
9. Acquired von Willebrand syndrome associated with left ventricular assist device.
Nascimbene A; Neelamegham S; Frazier OH; Moake JL; Dong JF
Blood; 2016 Jun; 127(25):3133-41. PubMed ID: 27143258
[TBL] [Abstract][Full Text] [Related]
10. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
Lison S; Dietrich W; Spannagl M
Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
[TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
[TBL] [Abstract][Full Text] [Related]
12. First clinical use of a bioprosthetic total artificial heart: report of two cases.
Carpentier A; Latrémouille C; Cholley B; Smadja DM; Roussel JC; Boissier E; Trochu JN; Gueffet JP; Treillot M; Bizouarn P; Méléard D; Boughenou MF; Ponzio O; Grimmé M; Capel A; Jansen P; Hagège A; Desnos M; Fabiani JN; Duveau D
Lancet; 2015 Oct; 386(10003):1556-63. PubMed ID: 26231456
[TBL] [Abstract][Full Text] [Related]
13. Immediate recovery of acquired von Willebrand syndrome after left ventricular assist device explantation: implications for heart transplantation.
Davis ME; Haglund NA; Tricarico NM; Matafonov A; Gailani D; Maltais S
ASAIO J; 2015; 61(1):e1-4. PubMed ID: 25251586
[TBL] [Abstract][Full Text] [Related]
14. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
[TBL] [Abstract][Full Text] [Related]
15. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
16. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B
Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469
[TBL] [Abstract][Full Text] [Related]
17. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
Favaloro EJ
Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
[TBL] [Abstract][Full Text] [Related]
18. Von Willebrand factor: another janus-faced hemostasis protein.
Franchini M; Mannucci PM
Semin Thromb Hemost; 2008 Oct; 34(7):663-9. PubMed ID: 19085767
[TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N
Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor disruption and continuous-flow circulatory devices.
Proudfoot AG; Davidson SJ; Strueber M
J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
